Oncolytics Today Fall 2023
Published Date: October 1, 2023
Publication Highlights
Oncology Faces a Host of Rising Challenges: NCODA takes a hard look at the oncology drug shortage, the Stark Law’s impact on prescription mailing, alternative funding programs, the Inflation Reduction Act and 340B abuse. Page 55
Executive Council Message: FALL 2023 ISSUE FOCUSES ON THE RISING CHALLENGES ONCOLOGY FACES. Page 7
Clinical Trials Four key questions to consider when critically appraising oncology clinical trials. Page 8
Mind & Body The emerging role of integrative therapy in cancer care. Page 11
Looking to the Future The role of the nurse in monitoring oral anticancer medicines. Page 15
Nursing Community: NCODA SCHOLARSHIP PROVIDES OPPORTUNITY FOR APPLICANT TO ATTEND ONS CONGRESS. Page 18
Financial Toxicity Why oncology practices should dedicate resources to help coordinate with patient assistance programs. Page 20
Insurance Denials Don’t take NO for an answer: Tips for navigating health insurance denials. Page 23
Health Advocacy How dedicated assistance helps empower chronically ill patients. Page 27
Oncology Institute: NCODA ONCOLOGY INSTITUTE BRINGS TOGETHER HEALTHCARE LEADERS & INDUSTRY PARTNERS. Page 30
Career Ladder Development A training strategy that helps promote pharmacy technician development while retaining staff. Page 39
Continuing Education A review of Domain I and Domain II of OPTA’s Oncology Pharmacy Technician Certification. Page 42
PQI Podcast: Page 66
Taking a BiTE Out of Cancer A look at the newest therapies on the market that utilize the T cell-engaging bispecific antibodies class. Page 78
The ABCs of DDD A review of testing considerations and barriers for dihydropyrimidine dehydrogenase deficiency. Page 83
Treating Neuropathy Current treatment modalities for chemotherapy-induced neuropathy. Page 86
Novel Melanoma Weapon Dual immunotherapy product provides a new weapon in the treatment of advanced melanoma. Page 91
Empowering Your Employees Ways that healthcare organizations can focus on employee engagement & job satisfaction to promote staff retention. Page 94
New Drug Roundup: FOOD AND DRUG ADMINISTRATION ANNOUNCES THE APPROVAL OF 10 NEW ORAL ONCOLYTICS. Page 97
Knowing Too Much, But Understanding Too Little Transitioning from healthcare provider to caregiver provides unique insight into the patient’s cancer journey. Page 103
Final Thoughts: THE POLITICS OF ONCOLOGY:WHY WE MUST GET MORE INVOLVED IN HEALTHCARE LEGISLATION. Page 106
To Request The Oncolytics Today Media Kit / Rate Card, Contact: partnership@ncoda.org
- Two issues in Spring (March) and Fall (October)
- Audience includes 10,000+ Oncology and Urology health professionals
- Print and digital formats available
- Multi-ad discounts available